Day One Announces Updated FIREFLY-1 Data for Tovorafenib
- LBF
- Sep 11, 2023
- 1 min read
Today, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S. Food and Drug Administration (FDA) for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG). Read more HERE.
Comments